Sort
40,608 grants matching “prostate cancer”
Targeting AR-NCoR Interaction in Prostate Cancer
$323,000Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Mechanics and Tissue Remodeling Integrating Computational and Experimental Systems (MATRICES)
$323,000Manu Platt · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2023 · EB
Targeting AR-NCoR Interaction in Prostate Cancer
$323,000Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2008 · CA
International Differences in Health, Longevity, and SES
$322,975James Patrick Smith · Rand Corporation · R01 · FY2012 · AG
Leukocytic Phenotypes Associated with BPH Progression
$322,971Simon W. Hayward · Endeavor Health Clinical Operations · P20 · FY2018 · DK
Development of Hsp90 inhibitors for the treatment of cancer
$322,961Brian S J Blagg · University Of Kansas Lawrence · R01 · FY2012 · CA
Steroid Metabolism in Castration-Resistant Prostate Cancer
$322,955Peter S Nelson · Beth Israel Deaconess Medical Center · P01 · FY2014 · CA
ADDRESSING TREATMENT RESISTANCE IN MODELS OF LETHAL PROSTATE CANCER BY IDENTIFYING NOVEL TARGETS FOR DRUG DISCOVERY
$322,929The Trustees Of Columbia University In The City Of New York · · FY2019 · Defense Health Agency
Role of Id1 in NSCLC Progression and Metastasis
$322,898Srikumar P Chellappan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
TRP Ca2+ Channels in the Skin
$322,870Haoxing Xu · University Of Michigan At Ann Arbor · R01 · FY2013 · AR
PET Imaging of Tumor Targeting & Role of T Lymphocytes.
$322,846Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2006 · CA
Elucidating a novel molecular biomarker for castration-resistant prostate cancer
$322,844Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
mTOR Therapy in Prostate Cancer: Signatures of Response and Biology of Resistance
$322,811Phillip G Febbo · Duke University · R01 · FY2007 · CA
Mechanisms promoting translocations and mature B cell lymphomas
$322,806Jing Hong Wang · University Of Colorado Denver · R01 · FY2015 · CA
Role of Beta 3 Integrin in Skeletal Metastasis
$322,785Katherine Nelson Weilbaecher · Washington University · R01 · FY2007 · CA
Research and Methods Core - Telehealth Research and Innovation for Veterans with Cancer (THRIVE)
$322,775Leah L. Zullig · New York University School Of Medicine · P50 · FY2023 · CA
A novel determinant of prostate cancer growth
$322,764Hannelore Heemers · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Prostate cancer prevention and treatment by sillibinin
$322,762Rajesh Agarwal · University Of Colorado Denver · R01 · FY2007 · CA
Breast and Prostate Cancer Data Quality and Patterns of Care Study
$322,751Xiaocheng Wu · Lsu Health Sciences Center · U01 · FY2007 · DP
Role of nucleosome dynamics in epigenetic inheritance
$322,750Chuanhe Yu · University Of Minnesota · R01 · FY2020 · GM
Clinical Radiation Physics Service
$322,697Robert Miller · Division Of Clinical Sciences - Nci · ZID · FY2021 · CA
A chemoenzymatic technology for the efficient synthesis of novel cryptophycins
$322,693David H Sherman · Alluvium Biosciences, Inc. · R41 · FY2009 · CA
Project 4: A Targetable Master Regulator of Lethal Prostate Cancer
$322,681Michael R Freeman · University Of California Los Angeles · P50 · FY2019 · CA
Exploiting drivers of androgen receptor signaling negative prostate cancer for pr
$322,663Scott A Tomlins · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Regulation of Polycomb Repressive Complex 1 by EZH2 Regulated microRNAs in Cancer
$322,663Sooryanarayana Varambally · University Of Michigan At Ann Arbor · R01 · FY2012 · CA